Abstract
Liver biopsy is the cornerstone of medical decision-making for a wide range of hepatic diseases in children. The indications for liver biopsy vary greatly depending on the ease of diagnosis with non-invasive tests, the need to stage of disease, and the role of histological evaluation in management of liver disease. Multiple methods of liver biopsy are available to the clinician and are utilized based on clinical circumstances, cost, and consideration of contraindications. Collaboration between the clinician and pathologist is important in order to handle the tissue sample appropriately and interpret the histology. The purpose of this paper is to provide a broad overview of liver biopsy indications, techniques, pre- and post-biopsy care and complications, interpretations, contraindications, recent advancements, and pitfalls that occur with liver biopsies.
Similar content being viewed by others
References
Nio M, Wada M, Sasaki H, Tanaka H. Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature. Surg Today. 2015;45:813–8.
Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatric Gastroenterol Nut. 2017;64:154–68.
Matthai J, Paul S. Evaluation of cholestatic jaundice in young infants. Indian Pediatr. 2001;38:893–8.
Nayak NC, Vasdev N. Neonatal cholestasis syndrome: Identifying the disease from liver biopsy. Indian Pediatr. 2002;39:421–5.
Yang JG, Ma DQ, Peng Y, Song L, Li CL. Comparison of different diagnostic methods for differentiating biliary atresia from idiopathic neonatal hepatitis. Clin Imaging. 2009;33:439–46.
Ranjani H, Mehreen TS, Pradeepa R, Anjana RM, Garg R, Anand K, et al. Epidemiology of childhood overweight and obesity in India: A systematic review. Indian J Med Res. 2016;143:160–74.
Schwimmer JB. Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2016;63:1718–25.
Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013;33:79–85.
Bartlett JA, Sanchez LG, Kabbany MN, Shah J, Mittal N, Alkhouri N, et al. The use of liver biopsy to determine the severity of nonalcoholic fatty liver disease in children across the United States. Proceedings of the NASPGHAN Annual Meeting; 2019 October 17–19, Chicago, IL. J Pediatr Gastroenterol Nutr. 2019;69: S1–437.
Ascher Bartlett J.M., Mittal N, et al. A Single Center Assessment of the 2017 NASPGHAN guidelines regarding liver biopsy in the diagnosis of NASH in pediatric patients. Proceedings of the NASPGHAN Annual Meeting; October 24–27, 2018, Hollywood, Fl.
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the study of liver diseases. Liver biopsy. Hepatology. 2009;49:1017–44.
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73.
Campbell MS, Reddy KR. Review article: the evolving role of liver biopsy. Aliment Pharmacol Ther. 2004;20:249–59.
Pokorska-Spiewak M, Kowalik-Mikolajewska B, Aniszewska M, Pluta M, Marczynska M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol. 2015;21:12141–9.
Schwarz KB, Rosenthal P, Murrary KF, Honegger JR, Hardikar W, Mittal N, et al. Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C. Hepatology. 2020;71:422–30.
Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158–64.
Haas JE, Feusner JH, Finegold MJ. Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer. 2001;92:3130–4.
Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol. 2004;99:1510–6.
Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol. 2013;59:814–29.
Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2004;23:441–5.
Jara P, Bortolotti F. Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr. 1999;29:163–70.
Chapin CA, Mohammad S, Bass LM, Taylor SA, Kelly S, Alonso EM. Liver biopsy can be safely performed in pediatric acute liver failure to aid in diagnosis and management. J Pediatr Gastroenterol Nutr. 2018;67:441–5.
Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology. 1998;27:1220–6.
Mogahed EA, Mansy YA, Al Hawi Y, El-Sayed R, El-Raziky M, El-Karaksy H. Blind percutaneous liver biopsy in infants and children: Comparison of safety and efficacy of percussion technique and ultrasound assisted technique. Arab J Gastroenterol. 2016;17:168–75.
Kader HA, Bellah R, Maller ES, Mamula P, Piccoli DA, Markowitz JE. The utility of ultrasound site selection for pediatric percutaneous liver biopsy. J Pediatr Gastroenterol Nutr. 2003;36:364–7.
Sherman KE, Goodman ZD, Sullivan ST, Faris-Young S, Group GS. Liver biopsy in cirrhotic patients. Am J Gastroenterol. 2007;102:789–93.
Yoshimatsu R, Yamagami T, Tanaka O, Miura H, Tanaka T, Suzuki T, et al. Comparison of fully automated and semi-automated biopsy needles for lung biopsy under CT fluoroscopic guidance. Br J Radiol. 2012;85:208–13.
Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology. 1996;23:1079–83.
Garcia-Compean D, Cortes C. Transjugular liver biopsy. An update. Ann Hepatol. 2004;3:100–3.
Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, et al. Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut. 2006;55:1789–94.
Srivastava A, Prasad D, Panda I, Yadav R, Jain M, Sarma MS, et al. Transjugular Versus Percutaneous Liver Biopsy in Children: Indication, Success, Yield, and Complications. J Pediatr Gastroenterol Nutr. 2020;70:417–22.
Vajro P, Hadchouel P, Hadchouel M, Bernard O, Alagille D. Incidence of cirrhosis in children with chronic hepatitis. J Pediatr. 1990;117:392–6.
Dezsofi A, Baumann U, Dhawan A, Durmaz O, Fischler B, Hadzic N, et al. Liver biopsy in children: Position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2015;60:408–20.
Matos H, Noruegas MJ, Goncalves I, Sanches C. Effectiveness and safety of ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol. 2012;42:1322–5.
Kozlovich SY, Sochet AA, Son S, Wilsey MJ. Same-day versus overnight observation after outpatient pediatric percutaneous liver biopsy: A retrospective cohort study. Pediatr Gastroenterol Hepatol Nutr. 2019;22:377–86.
Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR. Clinical characteristics and complications of pediatric liver biopsy: A single centre experience. Ann Hepatol. 2017;16:797–801.
Cohen MB, HH AK, Lambers D, Heubi JE. Complications of percutaneous liver biopsy in children. Gastroenterology. 1992;102:629–32.
Westheim BH, Ostensen AB, Aagenaes I, Sanengen T, Almaas R. Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr. 2012;55:82–7.
Tulin-Silver S, Obi C, Kothary N, Lungren MP. Comparison of transjugular liver biopsy and percutaneous liver biopsy with tract embolization in pediatric patients. J Pediatr Gastroenterol Nutr. 2018;67:180–4.
Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol. 2012;19:250–62.
Bolia R, Matta J, Malik R, Hardikar W. Outpatient liver biopsy in children: safety, feasibility, and economic impact. J Pediatr Gastroenterol Nutr. 2017;65:86–8.
Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: A quantitative reference standard. Hepatology. 1998;28:323–31.
Bilreiro C, Noruegas MJ, Goncalves I, Moreira A. Ultrasound-guided liver biopsies in children: A singlecenter experience and risk factors for minor bleeding. J Pediatr Gastroenterol Nutr. 2017;65:137–40.
Bejarano PA, Koehler A, Sherman KE. Second opinion pathology in liver biopsy interpretation. Am J Gastroenterol. 2001;96:3158–64.
Poddar U, Shava U, Yachha SK, Agarwal J, Kumar S, Baijal SS, et al. Beta-blocker therapy ameliorates hypersplenism due to portal hypertension in children. Hepatol Int. 2015;9:447–53.
Xu H, Cai R. Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Expert Rev Clin Pharmacol. 2019;12:859–65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabbani, T., Ascher Bartlett, J.M. & Mittal, N. Liver Biopsy in Children. Indian Pediatr 57, 734–740 (2020). https://doi.org/10.1007/s13312-020-1918-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1918-3